Showing 851-860 of 20379 results for "".
Screening and Prophylaxis for Venous Thromboembolism
https://reachmd.com/programs/advances-in-long-term-care-medicine/screening-and-prophylaxis-for-venous-thromboembolism/5825/Patients who have recently had orthopedic and other types of general surgery, those who have recently had a stroke, and those with an ongoing medical condition (such as heart disease) are at most risk for developing venous thromboembolic disease. Do most long-term care facilities screen for this conNatural History of Breast Cancer: Early Detection vs. Mortality
https://reachmd.com/programs/focus-on-cancer/natural-history-of-breast-cancer-early-detection-vs-mortality/4319/The widespread use of mammography to screen for breast cancer has resulted in a decrease in breast tumor detection, as well as decrease in mortality rates associated with the disease. But the natural course of malignant diseases such as different types of cancer can vary considerably. Is it possibleMitigating Risk in New IBD Treatments– IBD Pro Webinar Series
https://reachmd.com/programs/cme/mitigating-risk-in-new-ibd-treatments-ibd-pro-webinar-series/16004/Join us for this module of the IBD Pro Webinar Series presentation titled “How to Mitigate Risks in New Therapies”. The talk will include new medications, positioning, real world evidence, and the Foundation's EMR IBD Education Tool. The 45 minute presentation will be followed by a 15 minute quesFertility and Safety of IBD Medications During Pregnancy – IBD Pro Webinar Series
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/fertility-and-safety-of-ibd-medications-during-pregnancy-ibd-pro-webinar-series/16104/Join us for this IBD Pro Webinar Series presentation titled “Fertility and Safety of IBD Medications During Pregnancy”. The talk will include a discussion on fertility in IBD patients and the safety profile of IBD treatments during pregnancy. The 40-minute presentation will be followed by a 20-miInvestigating the Potential Link Between Chronic Tonsillitis and IgA Nephropathy
https://reachmd.com/programs/clinicians-roundtable/investigating-the-potential-link-between-chronic-tonsillitis-and-iga-nephropathy/27026/Dive into a study focused on chronic tonsillitis and its possible link to IgA nephropathy.Evidence Builds for Cell-Based Influenza Vaccines
https://reachmd.com/programs/medical-industry-feature/evidence-cell-based-influenza-vaccines/36269/Randomized controlled trials have shown data supporting the safety and efficacy of cell-based influenza vaccines in adults and children.1-4 However, effectiveness studies have historically relied on outcomes based on clinical diagnosis of influenza-like illness rather than test-confirmed influenza.5Why Integrating a Wellness Lounge into Your Practice Makes Sense
https://reachmd.com/topics/minimally-invasive/why-integrating-a-wellness-lounge-into-your-practice-makes-sense/35187/First-hand tips from a successful integrationCan We Prevent Psoriatic Arthritis Before Diagnosis?
https://reachmd.com/programs/living-rheum/prevent-psoriatic-arthritis-before-diagnosis/51050/As our understanding of psoriatic arthritis deepens, we're starting to turn our attention toward intervention: preventing the disease before it progresses or is officially diagnosed. Tune in to hear Dr. Laura Coates discuss the evolving landscape of psoriatic arthritis prevention and interception, iSpotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
https://reachmd.com/programs/cme/spotlight-on-systemic-sclerosis-pathophysiology-presentation-emerging-evidence/48716/Systemic sclerosis (SSc) is complex and often diagnosed late. Explore the vasculopathy-fibrosis axis as a key driver of disease progression and clinical manifestations. Learn to recognize phenotypic red flags for ILD, PAH, and renal crisis, and apply risk stratification strategies to guide earlier iLH vs hCG: Formulations and Physiological Differences
https://reachmd.com/programs/global-womens-health-academy/lh-vs-hcg-formulations-and-physiological-differences/9556/Join Dr. Sandro Esteves in this excerpt of his live presentation entitled LH vs. hCG: Formulations and Physiological Differences, delivered during EXCEMED’s First World Conference on Luteinizing Hormone in ART: Landing in Latin America held in Mexico City, Mexico on 7 April 2017. This presentation i